Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Revenue
Shin Nippon Biomedical Laboratories Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Revenue
¥26.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
CMIC Holdings Co Ltd
TSE:2309
|
Revenue
¥93.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Medinet Co Ltd
TSE:2370
|
Revenue
¥724.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
CellSource Co Ltd
TSE:4880
|
Revenue
¥4.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Revenue
¥12.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
WDB coco Co Ltd
TSE:7079
|
Revenue
¥4.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Revenue?
Revenue
26.7B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Revenue amounts to 26.7B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 26%. The average annual Revenue growth rates for Shin Nippon Biomedical Laboratories Ltd have been 21% over the past three years , 9% over the past five years , and 5% over the past ten years .